Literature DB >> 22537433

Is hepatitis C virus carcinogenic?

Stanley M Lemon1, David R McGivern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22537433      PMCID： PMC4422399          DOI： 10.1053/j.gastro.2012.01.045

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  37 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

2.  PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.

Authors:  Wei Qiu; Xinwei Wang; Brian Leibowitz; Wancai Yang; Lin Zhang; Jian Yu
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

3.  Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.

Authors:  Tetsuro Shimakami; Daisuke Yamane; Rohit K Jangra; Brian J Kempf; Carolyn Spaniel; David J Barton; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-03       Impact factor: 11.205

4.  Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.

Authors:  Anna S Lok; James E Everhart; Elizabeth C Wright; Adrian M Di Bisceglie; Hae-Young Kim; Richard K Sterling; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Timothy R Morgan
Journal:  Gastroenterology       Date:  2010-12-01       Impact factor: 22.682

5.  Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.

Authors:  Wegene Borena; Susanne Strohmaier; Annekatrin Lukanova; Tone Bjørge; Björn Lindkvist; Goran Hallmans; Michael Edlinger; Tanja Stocks; Gabriele Nagel; Jonas Manjer; Anders Engeland; Randi Selmer; Christel Häggström; Steinar Tretli; Hans Concin; Håkan Jonsson; Pär Stattin; Hanno Ulmer
Journal:  Int J Cancer       Date:  2011-09-08       Impact factor: 7.396

Review 6.  Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer.

Authors:  D R McGivern; S M Lemon
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

Review 7.  NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

Authors:  Tom Luedde; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

8.  Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.

Authors:  Mei-Hsuan Lee; Hwai-I Yang; Sheng-Nan Lu; Chin-Lan Jen; Shiou-Hwei Yeh; Chun-Jen Liu; Pei-Jer Chen; San-Lin You; Li-Yu Wang; Wei J Chen; Chien-Jen Chen
Journal:  J Clin Oncol       Date:  2010-09-20       Impact factor: 44.544

Review 9.  Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.

Authors:  Ashwani K Singal; Amanpal Singh; Sathya Jaganmohan; Praveen Guturu; Rajasekhara Mummadi; Yong-Fang Kuo; Gagan K Sood
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-30       Impact factor: 11.382

10.  Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Authors:  Alexander Thompson; Emanuele Di Angelantonio; Pei Gao; Nadeem Sarwar; Sreenivasa Rao Kondapally Seshasai; Stephen Kaptoge; Peter H Whincup; Kenneth J Mukamal; Richard F Gillum; Ingar Holme; Inger Njølstad; Astrid Fletcher; Peter Nilsson; Sarah Lewington; Rory Collins; Vilmundur Gudnason; Simon G Thompson; Naveed Sattar; Elizabeth Selvin; Frank B Hu; John Danesh
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245
View more
  47 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

2.  Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up.

Authors:  Siu-Ka Mak; Ho-Kwan Sin; Kin-Yee Lo; Man-Wai Lo; Shuk-Fan Chan; Kwok-Chi Lo; Yuk-Yi Wong; Lo-Yi Ho; Ping-Nam Wong; Andrew K M Wong
Journal:  Clin Exp Nephrol       Date:  2017-01-12       Impact factor: 2.801

3.  Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Nonhomologous End Joining.

Authors:  Tsu-I Chen; Yuan-Kai Hsu; Chia-Yi Chou; Yu-Hsin Chen; Shing-Tzu Hsu; Yan-Shuo Liou; Yu-Ching Dai; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

4.  Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.

Authors:  George N Ioannou; Pamela Green; Elliott Lowy; Elijah J Mun; Kristin Berry
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 5.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

Review 6.  Metabolic reprogramming: a hallmark of viral oncogenesis.

Authors:  P Lévy; B Bartosch
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

7.  Cell division cycle 34 is highly expressed in hepatitis C virus-positive hepatocellular carcinoma with favorable phenotypes.

Authors:  Keiko Takagi; Tadatoshi Takayama; Yutaka Midorikawa; Hiromasa Hasegawa; Takanaga Ochiai; Masamichi Moriguchi; Tokio Higaki; Masayoshi Soma; Hiroki Nagase; Kyoko Fujiwara
Journal:  Biomed Rep       Date:  2017-05-18

Review 8.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

Review 9.  Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Authors:  Ivan Rusyn; Stanley M Lemon
Journal:  Cancer Lett       Date:  2013-07-18       Impact factor: 8.679

Review 10.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.